Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AK › Dillingham › NPI 1689873739
Physician

Bristol Bay Area Health Corporation

Bristol Bay Area Health Corporation was paid $5.85M by Medicaid between Jan 2018 and Dec 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 69% of everything it billed.

33Billing provider infoBRISTOL BAY AREA HEALTH CORPORATION
DILLINGHAM, AK 99576
33aNPI1689873739assigned 07/17/2007
28Total paid$5.85M
24GClaims20,751
24DCodes billed12
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in Alaska

Rank by total paid#2 of 60
Median peer was paid$277K
This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official CLARK, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20183,914$1.38M
20193,528$1.34M
20202,200$651K
20211,967$490K
20224,230$772K
20232,728$695K
2024incomplete2,184$525K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 69% 12,917 11,416 $4.02M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 23% 3,664 3,310 $1.36M
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 4.5% 671 645 $262K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.6% 539 502 $208K
90686 <1% 287 284 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 333 320 $1K
97802 <1% 12 12 $25.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 512 486 $0.00
90656 0% 75 75 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 0% 1,715 1,626 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 13 13 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 0% 13 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCLARK, ROBERT (CEO)
Same official

Other billing entities under CLARK, ROBERT

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.